Elan Refused to Engage With Royalty Over Weekend, Chairman Says
Co. predicts “lengthy, and we think likely fruitless, effort to find a buyer willing to offer more than we are,” Royalty Pharma Chairman Rory Riggs says in letter today. * Elan has effectively been for sale for almost four months as a result of Royalty approach, Riggs says * If no buyer emerged in that time, it suggests none is interested at a price above Royalty’s offer, Riggs says.
To contact the reporter on this story: Makiko Kitamura in London at email@example.com
To contact the editor responsible for this story: Phil Serafino at firstname.lastname@example.org